NCT06907290 - A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2028

Conditions

Chronic Hepatitis D Infection

Interventions

DRUG

Brelovitug 300 mg

Route of administration- Subcutaneous Injection

DRUG

Brelovitug 900 mg

Route of administration- Subcutaneous Injection

DRUG

Delayed Treatment with Brelovitug 300mg

Route of administration- Subcutaneous Injection

Trial Locations (32)

8800

RECRUITING

703 Sliven, Sliven

10007

RECRUITING

245 New York, New York

10065

RECRUITING

256 New York, New York

10075

RECRUITING

253 New York, New York

RECRUITING

255 New York, New York

19104

RECRUITING

257 Philadelphia, Philadelphia

21287

RECRUITING

254 Baltimore, Baltimore

33166

RECRUITING

250 Miami, Miami

52242

RECRUITING

248 Lowa, Cities in Iowa

78215

RECRUITING

249 San Antonio, San Antonio

90033

RECRUITING

244 Los Angeles, Los Angeles

90805

RECRUITING

252 Long Beach, Long Beach

92647

RECRUITING

242 Huntington Beach, Huntington Beach

92840

RECRUITING

247 Garden Grove, Garden Grove

Unknown

RECRUITING

102 Melbourne, Melbourne

RECRUITING

101 Camperdown, Camperdown

RECRUITING

104 Liverpool, Liverpool

RECRUITING

705 Plovdiv, Plovdiv

RECRUITING

702 Bulgaria, Sofia

RECRUITING

706 Sofia, Sofia

RECRUITING

704 Stara Zagora, Stara Zagora

RECRUITING

231 Toronto, Toronto

RECRUITING

182 Tbilisi, Tbilisi

RECRUITING

211 Israel, Beersheba

RECRUITING

901 Chisinau, Chisinau

RECRUITING

001 Auckland, Auckland

RECRUITING

221 Karachi City, Karachi

RECRUITING

191 Istanbul, Istanbul

T6G 2G5

RECRUITING

234 Alberta, Edmonton

0105

RECRUITING

181 Tbilisi, Tbilisi

RECRUITING

183 Tbilisi, Tbilisi

01001

RECRUITING

110 Kyiv, Kyiv